|
FR2470599A1
(fr)
*
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
|
DE3237575A1
(de)
*
|
1982-10-09 |
1984-04-12 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue orale mopidamolformen
|
|
KR880002139B1
(ko)
*
|
1983-04-08 |
1988-10-17 |
베링거 인겔하임 리미티드 |
경구 투여용 정제의 제조방법
|
|
DE3314003A1
(de)
*
|
1983-04-18 |
1984-10-18 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
|
|
DE3320583A1
(de)
*
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
|
|
DE3320582A1
(de)
*
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
|
|
JPS6051106A
(ja)
*
|
1983-08-31 |
1985-03-22 |
Yamanouchi Pharmaceut Co Ltd |
塩酸アモスラロ−ル持続性製剤
|
|
US4867984A
(en)
*
|
1984-11-06 |
1989-09-19 |
Nagin K. Patel |
Drug in bead form and process for preparing same
|
|
CA1323833C
(en)
*
|
1987-04-28 |
1993-11-02 |
Yatindra M. Joshi |
Pharmaceutical compositions in the form of beadlets and method
|
|
GB8813032D0
(en)
*
|
1988-06-02 |
1988-07-06 |
Boehringer Ingelheim Int |
Antiviral pharmaceutical composition
|
|
US5064656A
(en)
*
|
1989-11-14 |
1991-11-12 |
Dr. Gergely & Co. |
Uncoated pharmaceutical reaction tablet
|
|
JPH0674206B2
(ja)
*
|
1989-12-28 |
1994-09-21 |
田辺製薬株式会社 |
放出制御型製剤およびその製法
|
|
US5364646A
(en)
*
|
1990-01-10 |
1994-11-15 |
Dr. Karl Thomae Gmbh |
Oral pharmaceutical forms of pimobendan
|
|
US6300362B1
(en)
|
1990-07-25 |
2001-10-09 |
Novartis Ag (Formerly Sandoz Ltd.) |
Stabilized pharmaceutical compositions comprising acid donors
|
|
HU222489B1
(hu)
*
|
1990-07-25 |
2003-07-28 |
Novartis Ag. |
Stabilizált gyógyszerkészítmények és eljárás az előállításukra
|
|
DK0585355T3
(da)
*
|
1991-05-20 |
1995-06-06 |
Tanabe Seiyaku Co |
Flerlagspræparat med reguleret frigivelse
|
|
US5302393A
(en)
*
|
1991-07-11 |
1994-04-12 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
Method for inhibiting biological degradation of implantation polymeric material, inhibitor thereof and implantation polymeric material containing the inhibitor
|
|
US5270047A
(en)
*
|
1991-11-21 |
1993-12-14 |
Kauffman Raymond F |
Local delivery of dipyridamole for the treatment of proliferative diseases
|
|
DE19845358A1
(de)
*
|
1998-10-02 |
2000-04-06 |
Roehm Gmbh |
Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
|
|
EP1093814A1
(en)
*
|
1999-10-22 |
2001-04-25 |
Boehringer Ingelheim Pharma KG |
Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
|
|
US7064130B2
(en)
*
|
2001-04-20 |
2006-06-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
|
|
DE10149674A1
(de)
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
JP4331930B2
(ja)
*
|
2001-10-17 |
2009-09-16 |
武田薬品工業株式会社 |
酸に不安定な薬物の高含量顆粒
|
|
US20030181488A1
(en)
*
|
2002-03-07 |
2003-09-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
|
|
EP1594503A2
(en)
|
2003-02-07 |
2005-11-16 |
Boehringer Ingelheim International GmbH |
Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders
|
|
DE10306179A1
(de)
|
2003-02-13 |
2004-08-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
|
|
RU2005136383A
(ru)
|
2003-04-24 |
2007-06-10 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Применение дипиридамола или мопидамола для лечения и предупреждения тромбоэмболических заболеваний и нарушений, вызываемыхизбыточным образованием и/или повышенным уровнем экспрессии тромбиновых рецепторов
|
|
DE10339862A1
(de)
*
|
2003-08-29 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
|
|
EP1579862A1
(en)
|
2004-03-25 |
2005-09-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
|
|
US8980894B2
(en)
|
2004-03-25 |
2015-03-17 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
|
|
BRPI0511054A
(pt)
*
|
2004-05-13 |
2007-11-27 |
Boehringer Ingelheim Int |
uso de dipiridamola para o tratamento de resistência a inibidores plaquetários
|
|
BG860Y1
(bg)
*
|
2004-09-17 |
2007-02-28 |
"Софарма" Ад |
Лекарствена форма на дипиридамол
|
|
RU2403033C2
(ru)
|
2005-03-22 |
2010-11-10 |
Лозан Фарма Гмбх |
Солюбилизированный ибупрофен
|
|
US20070087056A1
(en)
*
|
2005-08-09 |
2007-04-19 |
Claudia Guthmann |
Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
|
|
GB0517204D0
(en)
*
|
2005-08-22 |
2005-09-28 |
Novartis Ag |
Organic compounds
|
|
WO2007022956A2
(en)
*
|
2005-08-22 |
2007-03-01 |
Novartis Ag |
Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent
|
|
RU2490012C2
(ru)
*
|
2006-01-27 |
2013-08-20 |
Апталис Фарматех Инк |
Системы доставки лекарственного средства, содержащие слабощелочной селективный 5-ht3, серотониновый блокатор и органические кислоты
|
|
BRPI0707325A2
(pt)
*
|
2006-01-27 |
2011-05-03 |
Eurand Inc |
formulação de dosagem de liberação multiparticulada e método para preparação da mesma
|
|
US20070184110A1
(en)
*
|
2006-02-09 |
2007-08-09 |
Minutza Leibovici |
Dipyridamole extended-release formulations and process for preparing same
|
|
EP1920785A1
(en)
|
2006-11-07 |
2008-05-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Liquid preparation comprising a complex of pimobendan and cyclodextrin
|
|
WO2009085306A1
(en)
|
2007-12-28 |
2009-07-09 |
Impax Laboratories, Inc. |
Controlled release formulations of levodopa and uses thereof
|
|
US20090196935A1
(en)
*
|
2008-02-01 |
2009-08-06 |
Ahmed Salah U |
Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets
|
|
US8133506B2
(en)
*
|
2008-03-12 |
2012-03-13 |
Aptalis Pharmatech, Inc. |
Drug delivery systems comprising weakly basic drugs and organic acids
|
|
WO2010036975A2
(en)
*
|
2008-09-25 |
2010-04-01 |
Teva Pharmaceutical Industries Ltd. |
Dipyridamole and acetylsalicylic acid formulations and process for preparing same
|
|
US20110003005A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Gopi Venkatesh |
Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
|
|
WO2011014741A1
(en)
*
|
2009-07-31 |
2011-02-03 |
Artemis Health, Inc. |
Methods and compositions for cell stabilization
|
|
EP2361615A1
(en)
|
2010-02-19 |
2011-08-31 |
Alfred E. Tiefenbacher GmbH & Co. KG |
Dipyridamole prolonged-release tablet
|
|
EA201391758A1
(ru)
*
|
2011-05-24 |
2014-06-30 |
Тева Фармасьютикал Индастриз Лтд. |
Спрессованная сердцевина для фармацевтической композиции, содержащая органические кислоты
|
|
ES2924478T3
(es)
|
2012-03-15 |
2022-10-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
|
|
HUE054186T2
(hu)
|
2013-07-19 |
2021-08-30 |
Boehringer Ingelheim Vetmedica Gmbh |
Éterezett ciklodextrin-származékokat tartalmazó, tartósított, folyékony, vizes gyógyászati készítmény
|
|
EP3782614A1
(en)
|
2013-10-07 |
2021-02-24 |
Impax Laboratories, LLC |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
WO2015082389A1
(en)
|
2013-12-04 |
2015-06-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Improved pharmaceutical compositions of pimobendan
|
|
US10537570B2
(en)
|
2016-04-06 |
2020-01-21 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
|
|
EP4267113A4
(en)
|
2020-12-22 |
2025-02-12 |
Amneal Pharmaceuticals LLC |
LEVODOPA DOSING SCHEME
|
|
US11986449B2
(en)
|
2020-12-22 |
2024-05-21 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|